MMPs as therapeutic targets—Still a viable option?
- 6 July 2007
- journal article
- research article
- Published by Elsevier in Seminars in Cell & Developmental Biology
- Vol. 19 (1), 61-68
- https://doi.org/10.1016/j.semcdb.2007.06.006
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Macrophage Elastase (Matrix Metalloproteinase-12) Suppresses Growth of Lung MetastasesCancer Research, 2006
- Matrix Metalloproteases in Aberrant Fibrotic Tissue RemodelingProceedings of the American Thoracic Society, 2006
- Stage-Specific Action of Matrix Metalloproteinases Influences Progressive Hereditary Kidney DiseasePLoS Medicine, 2006
- Matrix metalloproteinases and tumor metastasisCancer and Metastasis Reviews, 2006
- What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?Cardiovascular Research, 2006
- Randomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18Journal of Clinical Oncology, 2005
- A Protective Role for Matrix Metalloproteinase-3 in Squamous Cell CarcinomaCancer Research, 2004
- Matrix Metalloproteinase-9 Genotype Influences Large Artery Stiffness Through Effects on Aortic Gene and Protein ExpressionArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Closure of the Blood-Brain Barrier by Matrix Metalloproteinase Inhibition Reduces rtPA-Mediated Mortality in Cerebral Ischemia With Delayed ReperfusionStroke, 2003
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002